End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EUR | -1.00% | -1.00% | -1.00% |
May. 29 | Neovacs: mRNA approach validated in preclinical trial | CF |
May. 27 | Neovacs: collaboration contract with INSERM team | CF |